These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 8457146)
1. The anti-HIV activity of the phytochemical alpha-terthienyl. Hudson JB; Harris L; Teeple A; Towers GH Antiviral Res; 1993 Jan; 20(1):33-43. PubMed ID: 8457146 [TBL] [Abstract][Full Text] [Related]
2. The anti-HIV activities of photoactive terthiophenes. Hudson JB; Harris L; Marles RJ; Arnason JT Photochem Photobiol; 1993 Aug; 58(2):246-50. PubMed ID: 8415917 [TBL] [Abstract][Full Text] [Related]
3. Light-mediated activities of thiarubrines against human immunodeficiency virus. Hudson JB; Balza F; Harris L; Towers GH Photochem Photobiol; 1993 Apr; 57(4):675-80. PubMed ID: 8389484 [TBL] [Abstract][Full Text] [Related]
4. Photoactive terthiophenes: the influence of serum on anti-HIV (human immunodeficiency virus) activities. Hudson JB; Marles RJ; Soucy-Breau C; Harris L; Arnason JT Photochem Photobiol; 1994 Dec; 60(6):591-3. PubMed ID: 7870765 [TBL] [Abstract][Full Text] [Related]
5. Neutralization of HIV-1 and inhibition of HIV-1-induced syncytia by 1,8-naphthalimide photoactive compound. Chanh TC; Lewis DE; Allan JS; Sogandares-Bernal F; Judy MM; Utecht RE; Matthews JL AIDS Res Hum Retroviruses; 1993 Sep; 9(9):891-6. PubMed ID: 8257636 [TBL] [Abstract][Full Text] [Related]
6. Effects of tubeimoside-1 on HIV core protein p24 and cytopathogenesis in vitro. Yu LJ; Ma RD; Jiang SB Zhongguo Yao Li Xue Bao; 1994 Mar; 15(2):103-6. PubMed ID: 8010099 [TBL] [Abstract][Full Text] [Related]
7. Disinfection of cell-associated and extracellular HIV-1 by PUVA treatment. Deichmann M; Sczakiel G; Haas R J Virol Methods; 1997 Oct; 68(1):89-95. PubMed ID: 9395143 [TBL] [Abstract][Full Text] [Related]
8. The importance of light in the anti-HIV effect of hypericin. Hudson JB; Harris L; Towers GH Antiviral Res; 1993 Feb; 20(2):173-8. PubMed ID: 8460933 [TBL] [Abstract][Full Text] [Related]
9. Old plants newly discovered: Cassia sieberiana D.C. and Cassia abbreviata Oliv. Oliv. root extracts inhibit in vitro HIV-1c replication in peripheral blood mononuclear cells (PBMCs) by different modes of action. Leteane MM; Ngwenya BN; Muzila M; Namushe A; Mwinga J; Musonda R; Moyo S; Mengestu YB; Abegaz BM; Andrae-Marobela K J Ethnopharmacol; 2012 May; 141(1):48-56. PubMed ID: 22326358 [TBL] [Abstract][Full Text] [Related]
10. Pentoxifylline inhibits acute HIV-1 replication in human T cells by a mechanism not involving inhibition of tumour necrosis factor synthesis or nuclear factor-kappa B activation. Navarro J; Punzón MC; Pizarro A; Fernández-Cruz E; Fresno M; Muñoz-Fernández MA AIDS; 1996 May; 10(5):469-75. PubMed ID: 8724037 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of HIV infection by baicalin--a flavonoid compound purified from Chinese herbal medicine. Li BQ; Fu T; Yan YD; Baylor NW; Ruscetti FW; Kung HF Cell Mol Biol Res; 1993; 39(2):119-24. PubMed ID: 7693133 [TBL] [Abstract][Full Text] [Related]
13. Cellular fatty acid synthase is required for late stages of HIV-1 replication. Kulkarni MM; Ratcliff AN; Bhat M; Alwarawrah Y; Hughes P; Arcos J; Loiselle D; Torrelles JB; Funderburg NT; Haystead TA; Kwiek JJ Retrovirology; 2017 Sep; 14(1):45. PubMed ID: 28962653 [TBL] [Abstract][Full Text] [Related]
14. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity. Jansen RW; Schols D; Pauwels R; De Clercq E; Meijer DK Mol Pharmacol; 1993 Nov; 44(5):1003-7. PubMed ID: 7902528 [TBL] [Abstract][Full Text] [Related]
15. Antiretroviral activity of furocoumarins plus UVA light detected by a replication-defective retrovirus. Miolo G; Tomanin R; De Rossi A; Dall'Acqua F; Zacchello F; Scarpa M J Photochem Photobiol B; 1994 Dec; 26(3):241-7. PubMed ID: 7853115 [TBL] [Abstract][Full Text] [Related]
16. Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light. Lambrecht B; Mohr H; Knüver-Hopf J; Schmitt H Vox Sang; 1991; 60(4):207-13. PubMed ID: 1656610 [TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of UK-201844, a novel inhibitor that interferes with human immunodeficiency virus type 1 gp160 processing. Blair WS; Cao J; Jackson L; Jimenez J; Peng Q; Wu H; Isaacson J; Butler SL; Chu A; Graham J; Malfait AM; Tortorella M; Patick AK Antimicrob Agents Chemother; 2007 Oct; 51(10):3554-61. PubMed ID: 17646410 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies. BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802 [TBL] [Abstract][Full Text] [Related]
19. Reduction of human immunodeficiency virus production and cytopathic effects by inhibitors of the Na+/K+/2Cl- cotransporter. Voss TG; Gatti PJ; Fermin CD; Garry RF Virology; 1996 May; 219(1):291-4. PubMed ID: 8623543 [TBL] [Abstract][Full Text] [Related]
20. [Dose-dependent inactivation of extracellular human immunodeficiency virus by miramistin]. Krivorutchenko IuL Vopr Virusol; 1998; 43(3):122-4. PubMed ID: 9702810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]